GSK’s Vaccine Reminder Service for MenB

TERMS & CONDITIONS: GSK MenB Vaccine Reminder Service 20219

This initiative is being sponsored by GlaxoSmithKline (GSK) (the "Initiative").

Initiative Period: May 1, 2017 – ongoing

How does the text reminder program work? Individuals will enroll via a web registration form. Individuals can select option to receive SMS text messages. Individuals will receive up to 2 status messages. All individuals enrolled in the program will receive an enrollment confirmation text message. We are not responsible if you don’t receive text messages due to any technical or server issues. Some parts of this program may not be supported by all mobile phones/devices. T-Mobile is not liable for delayed or undelivered messages. Call 1-888-825-5249 for more information. Message and Data Rates May Apply. Maximum frequency of 2 msgs/month.

Participant Requirements: You must have a wireless device of your own capable of 2-way messaging, be using a participating wireless carrier, and be a wireless service subscriber with text messaging service. Not all cellular phone providers carry the necessary service to participate. Check your phone capabilities for specific text messaging instructions.

Participant Opt-Out or Help: You may opt-out from participating at any time. Text STOP to 20219 or reply STOP to any message to opt-out. For help, text HELP to 20219 or reply HELP to any message, go to https://contactus.gsk.com/callback.html or call 1-888-825-5249.

Privacy Policy: http://us.gsk.com/en-us/privacy/

Notices

Costs: You will be charged the standard text messaging fee charged by your wireless carrier for each message you send or receive, in accordance with the terms of your cellular subscription plan. Other carrier-specific rates may apply, depending on your individual wireless pricing plan, in accordance with your wireless customer agreement. You are responsible for all applicable taxes. Consult your wireless service provider regarding its pricing plans. Participating Wireless Carriers: Alltel, AT&T Mobility, Cellular One, MetroPCS, Nextel, Sprint, T-Mobile, Verizon Wireless, and Virgin Mobile. The service is offered on an "as-is" basis and may not be available in all areas at all times and may not continue to work in the event of product, software, coverage or other changes made by your wireless carrier. Carriers are not responsible for delayed or undelivered messages.

Rights

Releases; No Warranties; Reservations

By participating, you agree to release and hold harmless Vodafone and Participating Wireless Carriers ("Released Parties") and their respective representatives, agents, successors, assigns, employees, officers and directors, from any and all liability, for loss, harm, damage, injury, cost or expense whatsoever including without limitation, property damage, personal injury and/or death which may occur in connection with this Initiative, and for any claims based on violation of law or infringement or violation of any rights of any person or entity, including, without limitation, violation of publicity rights, defamation, invasion of privacy.

Released Parties are not responsible for any printing, typographical, mechanical or other errors in associated promotional materials in connection with this Initiative. Participating Wireless Carriers and/or each of their respective subsidiaries, affiliates, shareholders, officers, directors, agents, representatives and employees are not responsible for this Initiative, and none of them will have any liability or responsibility for any claim arising in connection with participation in this Initiative.

The Released Parties make no warranties, and hereby disclaim any and all warranties, express or implied, concerning any prize or content furnished by third parties in connection with this Initiative. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, ALL SERVICES ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, AND THE RELEASED PARTIES HEREBY DISCLAIM ALL SUCH WARRANTIES, INCLUDING BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND/OR NON-INFRINGEMENT.

Released Parties are not responsible for technical, hardware, software, electronic, network, telephone or other communications malfunctions, errors or failures of any kind, errors in transmission, traffic congestion, lost or unavailable network connections, telephone connections, wireless phone connections, web site, Internet, or ISP availability, unauthorized human intervention, incomplete or inaccurate capture of entry information (regardless of cause) or failed, incomplete, garbled, jumbled or delayed transmissions which may limit or restrict your ability to send a message, including any injury or damage to your or any other person’s wireless device relating to or resulting from participating in this Initiative.

GSK reserves the right, in its sole discretion, to cancel, terminate, modify, extend or suspend this Initiative for any reason without notice, including, without limitation, virus, bugs, non-authorized human intervention, fraud or other causes beyond its control, including, without limitation, anything that affects the administration, security, fairness or proper conduct of this Initiative.

Important Safety Information
About BEXSERO

  • Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
  • The tip caps of the prefilled syringes contain natural rubber latex, which may cause allergic reactions in latex-sensitive individuals

Important Safety Information About BEXSEROImportant Safety Information
About BEXSERO

  • Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
  • The tip caps of the prefilled syringes contain natural rubber latex, which may cause allergic reactions in latex-sensitive individuals
  • Tell your healthcare professional if you are pregnant, plan to become pregnant, or are breastfeeding
  • Fainting can happen after getting BEXSERO. Sometimes people who faint can fall and hurt themselves. For this reason, your healthcare professional may ask you to sit or lie down for 15 minutes after receiving BEXSERO
  • The most common side effects are pain, redness or hardness at the injection site; muscle pain; fatigue; headache; nausea; and joint pain
  • Some individuals with weakened immune systems may have reduced immune responses to BEXSERO
  • Vaccination with BEXSERO may not result in protection in all vaccine recipients
  • Ask your healthcare professional about the risks and benefits of BEXSERO. Only a healthcare professional can decide if BEXSERO is right for you or your child